Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders

Details for Australian Patent Application No. 2005319454 (hide)

Owner Wyeth

Inventors Graziani, Edmund Idris; Pong, Kevin; Skotnicki, Jerauld

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005319454

PCT Pub. Number WO2006/068932

Priority 60/637,666 20.12.04 US

Filing date 15 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 9 August 2012

International Classifications

C07D 498/18 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/436

A61K 35/00 Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 25/16 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 498/22 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/068932 Priority application(s): WO2006/068932

9 August 2012 Application Accepted

  Published as AU-B-2005319454

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319455-Mitotic kinesin inhibitors

2005319452-Multi-band air curtain separation barrier